Dermata Therapeutics
DRMA | NASDAQ
$0.60
-$0.02 (-3.41%)
At close: Nov 16, 2026, 4:00 PM ET
$0.64
+$0.04 (+6.63%)
After-hours:
Nov 16, 2026, 5:48 PM ET
Dermata Therapeutics Company Profile
Company profile explainedCompany Profile
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Key Executives
| Name | Position |
|---|---|
| Gerald T. Proehl | Founder, President, Chief Executive Officer & Chairman |
| Kyri K. Van Hoose | Senior Vice President & Chief Financial Officer |
| Christopher J. Nardo | Senior Vice President & Chief Development Officer |
| David F. Hale | Co-Founder & Lead Independent Director |
| Kyra Peckaitis | Vice President of Marketing |
| Maria Bedoya Toro Munera | Senior Vice President of Regulatory Affairs & Quality Assurance |
| Sean Proehl | Associate General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 8-K | Current Report |
| Oct 21, 2026 | 424B3 | Filing |
| Oct 20, 2026 | EFFECT | Filing |
| Oct 09, 2026 | S-3 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 17, 2026 | 25-NSE | Filing |
| Aug 17, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 10-Q | Quarterly Report |
| Aug 11, 2026 | 8-K | Current Report |
Dermata Therapeutics
| Country | United States |
| IPO Date | Aug 13, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Gerald T. Proehl |
Contact Details
3525 Del Mar Heights Road San Diego,
California 92130 United States
Stock Details
| Ticker Symbol | DRMA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001853816 |
| CUSIP Number | 249845504 |
| ISIN Number | US2498455045 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove DRMA